Finabate 145mg Tablet 10's

The Finabate 145mg Tablet is a pharmaceutical product formulated with Fenofibrate IP 145 mg, a potent lipid-lowering agent belonging to the fibrate class of medications. This oral tablet is clinically indicated for the comprehensive management of dyslipidemia, specifically targeting elevated levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides in adult patients. It serves as an essential adjunct to dietary modifications and lifestyle interventions for patients requiring pharmacological lipid regulation.

This medication plays a crucial role in mitigating the risks associated with abnormal lipid profiles. By effectively reducing harmful lipid fractions and simultaneously increasing high-density lipoprotein (HDL) cholesterol, Finabate 145mg Tablet contributes to the prevention of serious cardiovascular events such as myocardial infarction and stroke. Furthermore, it is particularly valuable in managing severe hypertriglyceridemia, thereby reducing the risk of triglyceride-induced pancreatitis.

The therapeutic action of Fenofibrate is mediated through the activation of Peroxisome Proliferator-Activated Receptor alpha (PPARα). This activation leads to enhanced catabolism of triglyceride-rich particles, reduced hepatic production of very-low-density lipoprotein (VLDL), and increased synthesis of apolipoproteins A-I and A-II, which are integral components of HDL. This multifaceted mechanism ensures a significant improvement in the overall lipid profile, promoting better cardiovascular health outcomes.

Key Features : 

Contains Fenofibrate IP 145 mg as the active pharmaceutical ingredient
Effectively lowers elevated triglyceride and LDL cholesterol levels
Increases beneficial HDL cholesterol levels
Reduces the risk of cardiovascular events and pancreatitis
Designed for oral administration, typically once daily
Manufactured by Johnlee Pharmaceuticals Pvt. Ltd.
Supplied in convenient 10-tablet strips (Alu-Alu Pack)